-$89M
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Boyce SarahSep 5, 2025Sell50,000$49.9487$2.5M
Mosbrooker EricSep 3, 2025Sell6,563$47.0723$310,000
Gallagher Kathleen P.Sep 2, 2025Sell188$47.42$8,900
Boyce SarahAug 28, 2025Sell25,000$49.388$1.2M
Hughes Steven GeorgeAug 22, 2025Sell2,208$46.4047$100,000
McCarthy TeresaAug 15, 2025Sell10,000$46.5632$470,000
Hughes Steven GeorgeAug 13, 2025Sell1,542$46.66$72,000
Mosbrooker EricAug 6, 2025Sell124,687$44.0626$5.5M
LEVIN ARTHUR AAug 6, 2025Sell107,500$47.6175$5.1M
MacLean Michael FAug 6, 2025Sell30,914$42.7264$1.3M
WILSON TROY EDWARDAug 6, 2025Sell22,000$45$990,000
WILSON TROY EDWARDAug 6, 2025Sell17,777$45$800,000
WILSON TROY EDWARDAug 6, 2025Sell15,000$45$680,000
Hughes Steven GeorgeAug 6, 2025Sell33,983$42.7373$1.5M
Hughes Steven GeorgeAug 6, 2025Sell17,667$42.7373$760,000
Hughes Steven GeorgeAug 6, 2025Sell12,334$42.7373$530,000
Hughes Steven GeorgeAug 6, 2025Sell11,283$42.7373$480,000
Mosbrooker EricAug 6, 2025Sell6,120$44.0626$270,000
WILSON TROY EDWARDAug 6, 2025Sell7,500$45$340,000
Hughes Steven GeorgeAug 6, 2025Sell6,167$42.7373$260,000
Moriarty John BAug 4, 2025Sell2,245$36.21$81,000
Gallagher Kathleen P.Jun 17, 2025Sell911$30.24$28,000
Flanagan W. MichaelJun 11, 2025Sell20,000$32.8847$660,000
Gallagher Kathleen P.Jun 2, 2025Sell5,875$32.4822$190,000
Gallagher Kathleen P.May 1, 2025Sell5,875$32.3956$190,000
Gallagher Kathleen P.Apr 1, 2025Sell5,546$27.8274$150,000
Gallagher Kathleen P.Apr 1, 2025Sell329$27.8274$9,200
Boyce SarahMar 20, 2025Sell31,540$31.0578$980,000
Flanagan W. MichaelMar 20, 2025Sell11,780$31.0584$370,000
Hughes Steven GeorgeMar 20, 2025Sell9,578$31.0598$300,000
MacLean Michael FMar 20, 2025Sell7,935$31.0554$250,000
McCarthy TeresaMar 20, 2025Sell7,778$31.0598$240,000
Flanagan W. MichaelMar 11, 2025Sell20,000$30.1307$600,000
Gallagher Kathleen P.Mar 3, 2025Sell5,875$29.414$170,000
Gallagher Kathleen P.Feb 3, 2025Sell5,875$32.1563$190,000
Gallagher Kathleen P.Jan 22, 2025Sell5,629$30.1609$170,000
LEVIN ARTHUR AJan 21, 2025Sell1,872$28.5987$54,000
MacLean Michael FJan 21, 2025Sell1,665$28.5932$48,000
MacLean Michael FJan 21, 2025Sell1,622$28.5929$46,000
McCarthy TeresaJan 21, 2025Sell1,738$28.5931$50,000
McCarthy TeresaJan 21, 2025Sell1,221$28.5968$35,000
Flanagan W. MichaelJan 21, 2025Sell3,860$28.5967$110,000
Flanagan W. MichaelJan 21, 2025Sell1,812$28.592$52,000
Boyce SarahJan 21, 2025Sell5,659$28.5946$160,000
Boyce SarahJan 21, 2025Sell4,738$28.5932$140,000
Gallagher Kathleen P.Jan 21, 2025Sell1,817$28.593$52,000
Gallagher Kathleen P.Jan 21, 2025Sell1,295$28.59$37,000
Hughes Steven GeorgeJan 21, 2025Sell2,032$28.5906$58,000
Hughes Steven GeorgeJan 21, 2025Sell1,915$28.5955$55,000
Gallagher Kathleen P.Jan 21, 2025Sell670$28.5953$19,000
Flanagan W. MichaelDec 18, 2024Sell12,742$32.66$420,000
MacLean Michael FDec 18, 2024Sell11,151$32.66$360,000
Boyce SarahDec 18, 2024Sell31,855$32.66$1M
McCarthy TeresaDec 18, 2024Sell11,151$32.66$360,000
McCarthy TeresaDec 16, 2024Sell25,000$33.2642$830,000
Flanagan W. MichaelDec 11, 2024Sell24,000$35.7667$860,000
LEVIN ARTHUR ANov 19, 2024Sell3,323$42.1224$140,000
McCarthy TeresaNov 18, 2024Sell25,000$41.1408$1M
MacLean Michael FNov 6, 2024Sell65,182$45.3339$3M
MacLean Michael FNov 6, 2024Sell27,262$46.2188$1.3M
MacLean Michael FNov 6, 2024Sell13,875$45.3339$630,000
LEVIN ARTHUR AOct 21, 2024Sell5,000$46.6335$230,000
McCarthy TeresaOct 16, 2024Sell25,000$48.5204$1.2M
Thompson TamarOct 7, 2024Sell30,000$44.9753$1.3M
Flanagan W. MichaelOct 1, 2024Sell62,500$47.6178$3M
McCarthy TeresaSep 23, 2024Sell13,153$44.0004$580,000
Flanagan W. MichaelSep 23, 2024Sell13,153$44.0004$580,000
Flanagan W. MichaelSep 23, 2024Sell11,847$43.8926$520,000
Boyce SarahSep 23, 2024Sell32,880$44.0001$1.4M
MacLean Michael FSep 23, 2024Sell11,510$44$510,000
LEVIN ARTHUR ASep 19, 2024Sell5,000$45.7316$230,000
Flanagan W. MichaelSep 11, 2024Sell62,500$40.4002$2.5M
Flanagan W. MichaelSep 11, 2024Sell34,000$40.3987$1.4M
Flanagan W. MichaelSep 11, 2024Sell14,894$40.3972$600,000
McCarthy TeresaSep 11, 2024Sell25,000$40.4017$1M
LEVIN ARTHUR AAug 19, 2024Sell5,000$45.1893$230,000
Boyce SarahAug 6, 2024Sell28,000$43.3508$1.2M
LEVIN ARTHUR AJul 19, 2024Sell5,000$45.0138$230,000
Boyce SarahJul 9, 2024Sell28,000$39.9315$1.1M
LEVIN ARTHUR AJun 20, 2024Sell5,000$37.5901$190,000
MacLean Michael FJun 18, 2024Sell11,228$39.1294$440,000
Boyce SarahJun 18, 2024Sell32,074$39.1295$1.3M
Flanagan W. MichaelJun 18, 2024Sell10,106$39.1297$400,000
McCarthy TeresaJun 18, 2024Sell9,864$39.1294$390,000
Boyce SarahJun 14, 2024Sell35,767$40.0784$1.4M
Boyce SarahJun 13, 2024Sell164,233$40.076$6.6M
LEVIN ARTHUR AJun 13, 2024Sell60,000$40.0797$2.4M
MacLean Michael FJun 12, 2024Sell104,245$35.7153$3.7M
Boyce SarahJun 12, 2024Sell100,000$35.7302$3.6M
LEVIN ARTHUR AJun 12, 2024Sell40,000$35.0657$1.4M
Boyce SarahJun 4, 2024Sell28,000$27.4207$770,000
LEVIN ARTHUR AMay 20, 2024Sell5,000$29.8962$150,000
MacLean Michael FMay 14, 2024Sell75,000$28.2806$2.1M
Boyce SarahMay 7, 2024Sell28,000$25.5375$720,000
LEVIN ARTHUR AApr 19, 2024Sell5,000$22.8246$110,000
LEVIN ARTHUR AApr 3, 2024Sell20,000$27.1107$540,000
Boyce SarahApr 2, 2024Sell28,000$26.2471$730,000
LEVIN ARTHUR AMar 19, 2024Sell5,000$23.9695$120,000
MacLean Michael FMar 13, 2024Sell40,000$24.519$980,000
LEVIN ARTHUR AMar 12, 2024Sell25,000$22.0366$550,000
Boyce SarahMar 12, 2024Sell28,000$22.6315$630,000
LEVIN ARTHUR AMar 12, 2024Sell2,641$22$58,000
Boyce SarahMar 8, 2024Sell84,000$21.3894$1.8M
Boyce SarahMar 1, 2024Sell84,000$20.1346$1.7M
LEVIN ARTHUR AJan 22, 2024Sell1,859$10.13$19,000
Boyce SarahJan 22, 2024Sell5,092$10.13$52,000
Flanagan W. MichaelJan 22, 2024Sell4,129$10.13$42,000
McCarthy TeresaJan 22, 2024Sell2,065$10.13$21,000
MacLean Michael FJan 22, 2024Sell1,616$10.13$16,000

What's the latest insider transaction for Avidity Biosciences?

The most recent insider transaction for Avidity Biosciences was conducted by Boyce Sarah, who sold 50,000 shares on September 5, 2025 at a price of $49.95 per share.

Which insider has sold the most RNA stock over the last two years?

Boyce Sarah has sold the most RNA stock in the last 2 years, with a total value of $29M.

What is the total value of insider transactions for Avidity Biosciences (RNA) in the last 2 years?

The total value of insider transactions for Avidity Biosciences in the last 2 years is negative, amounting to -$89M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on Avidity Biosciences' market confidence?

Over the last 2 years, insider transactions for Avidity Biosciences have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.